Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Zhujiang Hospital
NRG Oncology
Centre Georges Francois Leclerc
University of Maryland, Baltimore
Sun Yat-sen University
UNICANCER
Northwestern University
Tampere University Hospital
University Health Network, Toronto